[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Drugs in Development, 2021

 US$ 3,000.00

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Drugs in Development, 2021 SUMMARY T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Drugs in Development, 2021 provides in depth an...

April 2021 55 pages

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Drugs in Development, 2021

 US$ 3,000.00

T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface Antigen T3/Leu 4 Epsilon Chain or CD3E) - Drugs in Development, 2021 SUMMARY T Cell Surface Glycoprotein CD3 Epsilon Chain (T Cell Surface...

April 2021 45 pages

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021

 US$ 3,000.00

T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Development, 2021 SUMMARY T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Drugs in Develo...

April 2021 50 pages

T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Drugs in Development, 2021

 US$ 3,000.00

T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Drugs in Development, 2021 SUMMARY T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antige...

April 2021 35 pages

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Drugs in Development, 2021

 US$ 3,000.00

TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Drugs in Development, 2021 SUMMARY TAR DNA Binding Protein 43 (TDP43 or TARDBP) - Drugs in Development, 2021 provides in depth analysis on TAR DNA Bindin...

April 2021 45 pages

Tauopathies (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Tauopathies (Central Nervous System) - Drugs in Development, 2021 SUMMARY Tauopathies (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Tauopathies pipeline landscape....

April 2021 65 pages

Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Tay-Sachs Disease pipeline lan...

April 2021 45 pages

Tenosynovial Giant Cell Tumor (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Tenosynovial Giant Cell Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Tenosynovial Giant Cell Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Tenosynovial Giant Cell...

April 2021 40 pages

Testicular Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Testicular Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Testicular Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Testicular Cancer pipeline landscape. The report...

April 2021 40 pages

Thioredoxin (Trx or ATL Derived Factor or Surface Associated Sulphydryl Protein or TXN) - Drugs in Development, 2021

 US$ 3,000.00

Thioredoxin (Trx or ATL Derived Factor or Surface Associated Sulphydryl Protein or TXN) - Drugs in Development, 2021 SUMMARY Thioredoxin (Trx or ATL Derived Factor or Surface Associated Sulphydryl Pro...

April 2021 30 pages

Thromboangiitis Obliterans (Buerger Disease) (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Thromboangiitis Obliterans (Buerger Disease) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Thromboangiitis Obliterans (Buerger Disease) (Cardiovascular) - Drugs in Development, 2021 provides a...

April 2021 30 pages

Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Thrombocytopenia pip...

April 2021 65 pages

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021

 US$ 3,000.00

Thrombopoietin Receptor (Myeloproliferative Leukemia Protein or Proto Oncogene c Mpl or CD110 or MPL) - Drugs in Development, 2021 SUMMARY Thrombopoietin Receptor (Myeloproliferative Leukemia Protein...

April 2021 50 pages

Thrombosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Thrombosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Thrombosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Thrombosis pipeline landscape. The report provides...

April 2021 105 pages

Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) - Drugs in Development, 2021

 US$ 3,000.00

Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) - Drugs in Development, 2021 SUMMARY Thromboxane A2 Receptor (Prostanoid TP Receptor or TBXA2R) - Drugs in Development, 2021 provides in dept...

April 2021 30 pages

Thymic Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Thymic Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Thymic Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Thymic Carcinoma pipeline landscape. The report pr...

April 2021 75 pages

Thymic Stromal Lymphopoietin (TSLP) - Drugs in Development, 2021

 US$ 3,000.00

Thymic Stromal Lymphopoietin (TSLP) - Drugs in Development, 2021 SUMMARY Thymic Stromal Lymphopoietin (TSLP) - Drugs in Development, 2021 provides in depth analysis on Thymic Stromal Lymphopoietin (TS...

April 2021 35 pages

Thymidine Kinase (TK or EC 2.7.1.21) - Drugs in Development, 2021

 US$ 3,000.00

Thymidine Kinase (TK or EC 2.7.1.21) - Drugs in Development, 2021 SUMMARY Thymidine Kinase (TK or EC 2.7.1.21) - Drugs in Development, 2021 provides in depth analysis on Thymidine Kinase (TK or EC 2.7...

April 2021 35 pages

Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2021

 US$ 3,000.00

Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2021 SUMMARY Thymidylate Synthase (TYMS or EC 2.1.1.45) - Drugs in Development, 2021 provides in depth analysis on Thymidylate Syntha...

April 2021 55 pages

Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Development, 2021 SUMMARY Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Development, 2021 provides an overview of the Thymoma (Thymic...

April 2021 50 pages

Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) - Drugs in Development, 2021

 US$ 3,000.00

Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) - Drugs in Development, 2021 SUMMARY Thyrotropin Receptor (Thyroid Stimulating Hormone Receptor or TSHR) - Drugs in Development, 202...

April 2021 30 pages

Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen/Activator Kringle or PLAT or EC 3.4.21.68) - Drugs in Development, 2021

 US$ 3,000.00

Tissue Type Plasminogen Activator (t Plasminogen Activator or Alteplase or Reteplase or Plasminogen/Activator Kringle or PLAT or EC 3.4.21.68) - Drugs in Development, 2021 SUMMARY Tissue Type Plasmino...

April 2021 30 pages

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Drugs in Development, 2021

 US$ 3,000.00

Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR2) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 2 (Toll/Interleukin 1 Receptor Like Protein 4 or CD282 or TLR...

April 2021 60 pages

Toll Like Receptor 5 (Toll/Interleukin 1 Receptor Like Protein 3 or TLR5) - Drugs in Development, 2021

 US$ 3,000.00

Toll Like Receptor 5 (Toll/Interleukin 1 Receptor Like Protein 3 or TLR5) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 5 (Toll/Interleukin 1 Receptor Like Protein 3 or TLR5) - Drugs in Deve...

April 2021 35 pages

Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021

 US$ 3,000.00

Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 9 (CD289 or TLR9) - Drugs in Development, 2021 provides in depth analysis on Toll Like Receptor 9 (CD289 or...

April 2021 75 pages

Toll Like Receptor Family (TLR) - Drugs in Development, 2021

 US$ 3,000.00

Toll Like Receptor Family (TLR) - Drugs in Development, 2021 SUMMARY Toll Like Receptor Family (TLR) - Drugs in Development, 2021 provides in depth analysis on Toll Like Receptor Family (TLR) targeted...

April 2021 35 pages

Tonic-Clonic (Grand Mal) Seizure (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Tonic-Clonic (Grand Mal) Seizure (Central Nervous System) - Drugs in Development, 2021 SUMMARY Tonic-Clonic (Grand Mal) Seizure (Central Nervous System) - Drugs in Development, 2021 provides an overvi...

April 2021 30 pages

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) - Drugs in Development, 2021

 US$ 3,000.00

TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY TRAF2 and NCK Interacting Protein Kinase (TNIK or EC 2.7.11.1) - Drugs in Development, 2021 provides...

April 2021 30 pages

Trans Activator Of Transcription (Tat) - Drugs in Development, 2021

 US$ 3,000.00

Trans Activator Of Transcription (Tat) - Drugs in Development, 2021 SUMMARY Trans Activator Of Transcription (Tat) - Drugs in Development, 2021 provides in depth analysis on Trans Activator Of Transcr...

April 2021 30 pages

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) - Drugs in Development, 2021

 US$ 3,000.00

Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) - Drugs in Development, 2021 SUMMARY Transferrin Receptor Protein 1 (T9 or p90 or CD71 or TFRC) - Drugs in Development, 2021 provides in dept...

April 2021 40 pages

Transferrin Receptor (TFR) - Drugs in Development, 2021

 US$ 3,000.00

Transferrin Receptor (TFR) - Drugs in Development, 2021 SUMMARY Transferrin Receptor (TFR) - Drugs in Development, 2021 provides in depth analysis on Transferrin Receptor (TFR) targeted pipeline thera...

April 2021 35 pages

Transformed Mycosis Fungoides (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Transformed Mycosis Fungoides (Oncology) - Drugs in Development, 2021 SUMMARY Transformed Mycosis Fungoides (Oncology) - Drugs in Development, 2021 provides an overview of the Transformed Mycosis Fung...

April 2021 35 pages

Transforming Growth Factor Beta 3 (TGFB3) - Drugs in Development, 2021

 US$ 3,000.00

Transforming Growth Factor Beta 3 (TGFB3) - Drugs in Development, 2021 SUMMARY Transforming Growth Factor Beta 3 (TGFB3) - Drugs in Development, 2021 provides in depth analysis on Transforming Growth...

April 2021 30 pages

Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021

 US$ 3,000.00

Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021 SUMMARY Transforming Growth Factor Beta (TGFb) - Drugs in Development, 2021 provides in depth analysis on Transforming Growth Factor...

April 2021 95 pages

Transforming Growth Factor (TGF) - Drugs in Development, 2021

 US$ 3,000.00

Transforming Growth Factor (TGF) - Drugs in Development, 2021 SUMMARY Transforming Growth Factor (TGF) - Drugs in Development, 2021 provides in depth analysis on Transforming Growth Factor (TGF) targe...

April 2021 30 pages

Transient Receptor Potential Cation Channel Subfamily V Member 4 (Osm 9 Like TRP Channel 4 or Vanilloid Receptor Like Protein 2 or TRPV4) - Drugs in Development, 2021

 US$ 3,000.00

Transient Receptor Potential Cation Channel Subfamily V Member 4 (Osm 9 Like TRP Channel 4 or Vanilloid Receptor Like Protein 2 or TRPV4) - Drugs in Development, 2021 SUMMARY Transient Receptor Potent...

April 2021 30 pages

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 provides an...

April 2021 160 pages

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021 SUMMARY Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021...

April 2021 170 pages

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021

 US$ 3,000.00

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021 SUMMARY Transitional Endoplasmic Reticulum ATP...

April 2021 35 pages

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021

 US$ 3,000.00

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021 SUMMARY Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs...

April 2021 40 pages

Transplant Rejection (Immunology) - Drugs in Development, 2021

 US$ 2,000.00

Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Transplant Rejection pipeline landscap...

April 2021 80 pages

Trauma (Other Diseases) - Drugs in Development, 2021

 US$ 2,000.00

Trauma (Other Diseases) - Drugs in Development, 2021 SUMMARY Trauma (Other Diseases) - Drugs in Development, 2021 provides an overview of the Trauma pipeline landscape. The report provides comprehensi...

April 2021 45 pages

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 30 pages

Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Traveler's Diarrhea pipeline...

April 2021 40 pages

Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021 SUMMARY Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021 provides an overview o...

April 2021 65 pages

Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphoribosylformylglycinamidine Cyclo Ligase or GART or EC 2.1.2.2 or EC 6.3.3.1 or EC 6.3.4.13) - Drugs in Development, 2021

 US$ 3,000.00

Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphoribosylformylglycinamidine Cyclo Ligase or GART or EC...

April 2021 30 pages

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) - Drugs in Development, 2021

 US$ 3,000.00

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) - Drugs in Development, 2021 SUMMARY Triggering Receptor Expressed On Myeloid Cells 1...

April 2021 30 pages

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021

 US$ 3,000.00

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021 SUMMARY Triggering Receptor Expressed On Myeloid Cells 2 (Triggeri...

April 2021 30 pages

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Tropom...

April 2021 50 pages

Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Trypanosomiasis pipeline landsca...

April 2021 35 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1